What's new

Human medicines European public assessment report (EPAR): Nplate, romiplostim, Date of authorisation: 04/02/2009, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Nplate, romiplostim, Date of authorisation: 04/02/2009, Revision: 29, Status: Authorised

Mar 31, 2025 - 14:48
 0
Human medicines European public assessment report (EPAR): Nplate, romiplostim, Date of authorisation: 04/02/2009, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Nplate, romiplostim, Date of authorisation: 04/02/2009, Revision: 29, Status: Authorised
Read More

Tags:

Previous Article

New Skoda Enyaq launched with range of 365 miles

Next Article

Powering the future: Utility leaders’ take on program challenges and opportunities

Related Posts

Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025  0

Clinical Trials Information System (CTIS): Information day, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 22 May 2025, 12:30 (CEST) to 22 May 2025, 17:30 (CEST)

Clinical Trials Information System (CTIS): Information ...

Mar 28, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Sarclisa, Isatuximab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: P/0049/2024

Opinion/decision on a Paediatric investigation plan (PI...

Apr 1, 2025  0